← Back to Search

Ketone Ester

Avela™ (R)-1,3-Butanediol for Healthy Subjects

N/A
Waitlist Available
Research Sponsored by Genomatica Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 30, 60, 90, 120, 180, 240, and 300 minutes
Awards & highlights

Summary

This trial tests a special drink containing (R)-1,3-butanediol to see how it affects ketone levels in the blood. It also looks at how the drink impacts stomach comfort and alertness. The body turns (R)-1,3-butanediol into ketones, which can be used for energy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 30, 60, 90, 120, 180, 240, and 300 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 30, 60, 90, 120, 180, 240, and 300 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the level of production of BHB measure of blood ketones levels (i.e., blood BHB levels)
Secondary study objectives
To assess GI symptomology
To assess Sleepiness/alertness

Trial Design

1Treatment groups
Experimental Treatment
Group I: Avela™ (R)-1,3-ButanediolExperimental Treatment1 Intervention
3 servings of Avela™, with consumption of each serving separated by 30 minutes and each serving providing 11.5 g of (R)-1,3-butanediol \[total intake of 34.5 g of (R)-1,3-butanediol\].

Find a Location

Who is running the clinical trial?

Genomatica Inc.Lead Sponsor
~9 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top